Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers
journal contributionposted on 02.06.2021, 09:19 by Vincent VuaroqueauxVincent Vuaroqueaux, Hans R Hendriks, Hoor Al-HasaniHoor Al-Hasani, Anne-Lise Peille, Samayita Das, Heinz-Herbert Fiebig
Meta data and molecular information related to the study. A dictionary file (Tables_dictionary) is given in which each file is briefly described and information of its availability is given.
The tables include: tables of meta information of the used CL in the study for the two compounds MI-773 and Nutlin-3a; genetic & transcriptomic information of the 237 CLs used for biomarker investigation of MI-773 compound (whole exome mutations and Affymetrix Genome-Wide Human SNP Array 6.0 (SNP6.0), Affymetrix HGU133 Plus 2.0).